-
Adam Feurstein Says Clinical Data Could Be Acquired (CLDA)
Wednesday, February 2, 2011 - 4:21pm | 55According to a tweet by theStreet.com's Adam Feurstein, a Bloomberg reporter said that Clinical Data (NASDAQ: CLDA) will either be acquired or market vilazodone on its own. CLDA shares have pulled back sharply in the last few minutes, but are still up 2.31% on the session at $31.07.
-
Hospira Down 6.9% On Earnings Miss (HSP)
Wednesday, February 2, 2011 - 3:54pm | 183Shares of Lake Forest, Illinois-based Hospira Inc. (NYSE: HSP) are trading down 6.9% at $51.28 per share during the Wednesday afternoon trading session. The day's trading range for shares of Hospira Inc has been between $49.51 and $51.48 per share. Analysts covering the company's stock give it a...
-
Hospira Misses; 2011 View Weak - Analyst Blog
Wednesday, February 2, 2011 - 2:31pm | 806Hospira Inc.(HSP) reported earnings per share of 77 cents for the fourth quarter of 2010, much below the Zacks Consensus Estimate of 93 cents and the year-earlier earnings of 87 cents. The lackluster earnings performance was due to lower revenues and higher research and development expenses....
-
Hospira Misses; 2011 View Weak - Analyst Blog
Wednesday, February 2, 2011 - 2:15pm | 806Hospira Inc.(HSP) reported earnings per share of 77 cents for the fourth quarter of 2010, much below the Zacks Consensus Estimate of 93 cents and the year-earlier earnings of 87 cents. The lackluster earnings performance was due to lower revenues and higher research and development expenses....
-
Covidien Outshines, Backs View - Analyst Blog
Wednesday, February 2, 2011 - 1:31pm | 1217International medical technology giant Covidien plc (COV) reported first-quarter fiscal 2011 (ended December 24) adjusted earnings per share (from continuing operation) of 95 cents, outstripping the Zacks Consensus Estimate of 81 cents and exceeding the year-ago earnings of 84 cents. Adjusted...
-
Covidien Outshines, Backs View - Analyst Blog
Wednesday, February 2, 2011 - 1:00pm | 1217International medical technology giant Covidien plc (COV) reported first-quarter fiscal 2011 (ended December 24) adjusted earnings per share (from continuing operation) of 95 cents, outstripping the Zacks Consensus Estimate of 81 cents and exceeding the year-ago earnings of 84 cents. Adjusted...
-
Options Brief: Hospira, Inc. (HSP)
Wednesday, February 2, 2011 - 12:58pm | 85Shares of Hospira, Inc. (NYSE: HSP) are lower on the session by 7.08%, trading at $51.15. Overall put volume is now running at 5.73x the daily average, with 17% of all puts traded being purchases on the offer. 3,731 contracts have traded on the session so far. Hospira, Inc. is a specialty...
-
Wells Fargo Initiates NxStage Medical at Underperform (NXTM)
Wednesday, February 2, 2011 - 12:30pm | 142Wells Fargo is out with its report today on NxStage Medical (NASDAQ: NXTM), initiating NXTM at Underperform. In a report sent to clients, Wells Fargo writes, "We are initiating coverage of NxStage Medical, Inc. with an Underperform rating. While home hemodialysis receives high marks for patient...
-
Kinetic Tops EPS, Revs Matches - Analyst Blog
Wednesday, February 2, 2011 - 11:01am | 618Kinetic Concepts (KCI) reported an EPS of $1.03 for the fourth quarter of fiscal 2010 compared to 93 cents in the year-ago quarter. However, adjusted EPS was $1.17, beating the Zacks Consensus Estimate of $1.15 and the year-ago quarter's earnings of $1.10. For fiscal 2010, adjusted EPS came in at...
-
Kinetic Tops EPS, Revs Matches - Analyst Blog
Wednesday, February 2, 2011 - 10:45am | 618Kinetic Concepts (KCI) reported an EPS of $1.03 for the fourth quarter of fiscal 2010 compared to 93 cents in the year-ago quarter. However, adjusted EPS was $1.17, beating the Zacks Consensus Estimate of $1.15 and the year-ago quarter's earnings of $1.10. For fiscal 2010, adjusted EPS came in at...
-
Goldman Sachs Morning Summary
Wednesday, February 2, 2011 - 10:42am | 207Goldman Sachs is out with its research report on the Americas this morning. Goldman Sachs upgraded its Quest Software (NASDAQ: QSFT) rating to Neutral from Sell, downgraded Nuance Communications (NASDAQ: NUAN) to Sell from Neutral, raised Pfizer's (NYSE: PFE) price target to $22 from $20, raised...
-
Jefferies Remains On Boston Scientific Sidelines, Hold Rating (BSX)
Wednesday, February 2, 2011 - 10:02am | 153Jefferies stated it will remain on Boston Scientific (NYSE: BSX) sidelines with a Hold rating pending further information, in a research report published today. In the report, Jefferies states, "Boston Scientific has new management with a plan for improving performance. However, it remains to be...
-
Kinetic Concepts 4Q In-Line With Pre-Announcement, Piper Jaffray Raises PT To $46
Wednesday, February 2, 2011 - 10:01am | 213Piper Jaffray has published a research report on Kinetic Concepts, Inc. (NYSE: KCI) after the company reported earnings that were in-line with the pre-announcement Kinetic Concepts published in January. In the report, Piper Jaffray writes "Results were in line with KCI's pre-release in early...
-
Covidien Reports Strong Quarter, PT Raised To $56
Wednesday, February 2, 2011 - 9:49am | 136Piper Jaffray has published a research report on Covidien, Ltd. (NYSE: COV) after the company reported a strong, in-line quarter with revenues coming in with what analysts expected. In the report, Piper Jaffray writes "Revenues were in line with what we expected at $2.77B (up 5%); medical devices...
-
Hospira Shares Fall 5.6% On Estimate Miss (HSP)
Wednesday, February 2, 2011 - 9:38am | 194Lake Forest, Illinois-based Hospira Inc. (NYSE: HSP) announced on Wednesday morning that it failed to meet consensus Wall Street estimates. Hospira Inc reported that its 4th quarter net income fell 37.3% to $60.6 million, or 36 cents per share, down from $96.7 million, or 58 cents per share, a year...